Information And Analysis On Medical Equipment Markets

Navi Mumbai, India (PressExposure) March 18, 2009 -- The new report entitled, “Top 10 Medical Equipment Trends in 2009” ( [] )is an essential source of intelligence and insight on the key medical equipment market trends in the year ahead. Drawing from unique global databases of market value, product sales, competitor shares, key events, financial deals and pipeline products, the report identifies the key trends, expected to influence the global medical equipment market landscape in 2009.

A strong understanding of the trends will prove to be a decisive factor in strategic planning and decision making for all involved in the value chain - investors, manufacturers, distributors, regulators, payer/providers and analysts tracking this industry

Obama Plans To Bring Stellar Growth For Healthcare Information Technology

Driven by the realization of an ever-increasing necessity to strengthen and streamline healthcare delivery and management, the US Healthcare Information Technology (IT) market which was valued at $3.4 billion in 2007 is expected to grow by 14.6% annually to reach $6.72 billion by 2012.

Barack Obama’s plan to tackle health issues brings a positive development for medical device manufacturers, particularly in the Healthcare IT sector, where it is forecast to drive nearly 15% per annum growth. Given the recent downtrend in the market and lack of credit, Obama’s plan provides an excellent opportunity for Medical Companies as the number of people going from uninsured to insured will be increasing. Under Obama’s plan, insurance companies will be forced to insure people with a history of health issues. That should be a welcome sign as reimbursements for such individuals continue to pile up. $10 billion investment over 5 years in Healthcare IT is a long standing change needed for the health care system to move from paper based records to standardized electronic based systems. This will allow medical insurance portability from job to job and across state lines, making it easier for employers to provide insurance to their employees, Above all making health insurance affordable to 45 million uninsured people should increase the number of individuals using medical devices.

Home Healthcare Equipment Market Is Poised For A Big Return In 2009 Owing To Cost Containment Efforts By Both Providers And Purchasers

Consumers’ interest in their health is increasing the opportunities for home healthcare device manufacturers who provide a connected view of the individual’s well being. The forecast upcoming recession will lead more people to treat themselves at home. Healthcare equipment like Continuous Positive Airway Pressure (CPAP) Devices, nebulizers, drug delivery devices, digital signal processing hearing aids, glucose monitoring systems and self test (IVD) devices are set for a high single digit to double digit growth rate in the next 5 years. This trend is gaining prominence because of the need to reduce medical costs. This is leading to better reimbursement rates from insurers. The global market for home healthcare devices is set to grow by more than 9% from 2007 to 2012 with the market exceeding $70 billion in 2012.   Emerging Medical Equipment Markets Will Continue To Grow In 2009, Assisted By The Ongoing Trend Towards Medical Tourism And Helping To Offset Any Negative Impact Felt By The General Economic Downturn  

Multinational companies will continue to relocate manufacturing operations in emerging economies to ensure that they can capitalize on the increased wealth and healthcare spend allocated by consumers and governments in key markets like China, Brazil, India and Taiwan in 2007. As governments continue to remove restrictions on medical imports and the ability of foreign manufacturers to enter key markets, we can expect to see multinational companies increase market share and dominate key sectors and help drive the growth of medical tourism.

Medical tourism is one of the fastest growing industries and countries like India, Thailand, Singapore and Philippines have become favorite destinations for patients from developed countries. Huge price differentials, availability of advanced technologies in private hospitals and highly skilled medical professionals in these countries are driving the medical tourism business. In 2002, Indian medical tourism generated $300 million in revenue. Since 2002 there has been an increase of 25% in medical tourists to India. Indian medical tourism revenue is forecast to reach $2 billion in 2012 when compared with $800 million in 2007 with a growth rate of 29% CAGR from 2007 to 2012.

Major Medical Equipment Manufacturers To Remain Stable In Spite Of Mounting Financial Crisis

The impact of the credit crunch on medical device companies, and particularly their Research and Development (R&D) spend has been limited. Most of the big companies are still committing an average of 10% of their revenues towards R&D. Companies with more diversified portfolios are less susceptible to market fluctuations, hence they are likely to remain stable in the face of the global economic turmoil.

For example, Abbott is raising its guidance for the full-year 2008. The company reported double-digit sales growth in each major global business with worldwide sales growth of 17% in the third quarter for 2008 when compared with the third quarter of 2007. Similarly Medtronic recorded 2009 first quarter revenue of $3.706 billion, a 19 percent increase over the $3.127 billion reported in the first quarter of fiscal year 2008. Smith & Nephew reported a revenue growth of 9% with a trading profit of 3% in third quarter of 2008 when compared with 2007. All these companies along with Johnson & Johnson, Baxter, Cardinal Health, and B Braun, 3M Health Care, Roche Diagnostics and Becton Dickinson are volume driven, which makes them less risk prone to the ongoing financial crisis. Another big factor that is insulating the medical device companies from the current economic concerns is Medical Professionals unwillingness to switch from a product they are comfortable with. Unlike the pharmaceuticals and biotech industries which are characterized by lengthy product development, regulatory approval processes, patent law suites and huge R&D investments, medical equipment companies are cash rich and do not have many patent issues.   Direct To Consumer Advertising Of Medical Devices To Continue To Increase In Prominence In 2009

The Direct to Consumer (DTC) Advertising approach has been employed by medical device manufacturers for the past few years with some impressive results, a trend that is set to continue as the “baby boomer” generation continues to age. Notable among companies employing this strategy is Stryker which has been running ads using golf legend Jack Nicklaus to promote Trident® Acetabular, a ceramic replacement hip, Zimmer Holdings promoting replacement knees for women, Medtronic advertising heart defibrillators.

The amount spent by the medical device industry for DTC Advertising through television and the internet was approximately $195 million in 2007 nearly doubling the amount spent in 2005. This is a significant amount when compared to almost no spending on DTC Advertising by medical device companies in 1996, especially considering $1.5 billion spent by medical device companies in 2005 on special trade journals that are typically accessed by doctors and hospitals.

In the US, the number of people, 65 or older, roughly stand at 37 million in 2007 and is likely to reach 40 million approximately in 2010 and 55 million in 2020. On average, every 8 seconds a person from the baby boom generation turns 50 and the trend will continue over the next 10 years. A lot of baby boomers may require procedures for heart, knee, and hip at a young age when compared to their previous generations. Increased life expectancy and changing demographic trends may ultimately lead to increased usage of medical devices, especially in markets like diabetes, cardiology, orthopedics, neurology, diagnostic imaging. DTC Advertising ultimately drives the patients to seek medical attention thereby increasing the volume of patients, improves compliance, improves sales, builds the brand name and acts as a powerful tool for companies in terms of recruiting people for trials.   Healthcare Information Technology Spend To Gain Significant Attention In 2009 And Beyond From Both Developed And Emerging Economies

Mr Barack Obama’s win in the US Presidential Election boosts the prospects of Healthcare IT in the US market in the next 5 to 10 years. To improve quality and efficiency and reduce healthcare costs, Obama’s plan of investing $10 billion over 5 years is a sign of IT’s importance in Healthcare. Healthcare IT has not only received attention from medical equipment manufacturers but also from big IT companies like Microsoft, Cognizant, IBM, and Intel among others.

Healthcare IT has also received a boost from India and China with their planned investment in Healthcare in rural and middle tier cities. The Indian government went a step ahead offering a 5 year tax holiday for companies setting up hospitals and clinics in rural and middle tier cities. Apparent advantages of Healthcare IT is that it will force both the governments and healthcare providers towards long term investment in this sector and will be a trend in both developed and emerging economies. The Healthcare IT market in India is to grow at a rate of 7.5% CAGR from 2007 to 2012. This is significantly higher when compared with the previous year’s growth of 4.6% CAGR from 2000 to 2007.   Drug Eluting Stents On A Comeback Trail In The US Market In 2009

A US FDA statement saying that the use of Drug Eluting Stents (DES) are safe and have very minimum risk when they are used “on-label” should significantly improve the US market for DES. Positive results from Boston Scientific’s TAXUS HORIZONS AMI trial, Abbott Laboratories SPIRIT I, II, III trial and Medtronic's Third-Generation Endeavor® Resolute trial has renewed the faith in the product. One important outcome of these trials was that DES implantations not only open blocked coronary arteries but also chemically inhibit future blockage.

This is evident in the third quarter results of Boston Scientific, Abbott Laboratories and Medtronic Corporation. The tremendous reception and sales of Abbott’s XIENCE V puts doubts about the safety of DES to rest. As a result is forecasting a growth rate of 5% CAGR from 2008 to 2012 for the DES market in the US. This is a complete turnaround from the negative growth seen in 2006 and 2007.

Young Adults And Middle Aged Patients To Drive The US Market For Hip Resurfacing For Next Five Years

The US hip resurfacing market is set to grow in double digits during 2007 – 2012 but not as quickly as expected by some industry sources. The growth limiting factor is the patient pool comprising of adults and middle aged patients with good bone stock. Another factor contributing to the lower than expected growth is the limited number of doctors performing the hip resurfacing procedure. This is very small market in the US dominated by Smith & Nephew. Stryker entered the US market for hip resurfacing in 2007 with limited success so far. With no visible entrance of new companies in the near future, Smith & Nephew is set to dominate the US hip resurfacing market for a long time. The hip resurfacing market in the US is set to grow from 16 million in 2006 to 220 million in 2012 with a growth rate of 55% CAGR over the same time period.

Cash Rich And Innovative Companies To Benefit In The Current Economic Scenario

Low equity prices will give an opportunity for big companies to go after innovative companies developing products in niche markets for an equity share instead of financing. A prime example of this is Bausch & Lomb’s equity investment to acquire a minority share and securing exclusive rights to purchase - AcuFocus, Inc., a privately held company located in Irvine, California in January, 2007. The primary reason for Bausch & Lomb’s investment in AcuFocus Inc is to gain access to the corneal implant technology and AcuFocus ACI 7000. Big companies like Getinge, Hologic Corporation and small and upcoming companies like Small Bone Innovations, Core Essence Orthopaedics will be most watched for their existing and coming product lines.   Products Related To Women’s Health, Minimally Invasive Surgery And Home Healthcare Are Set To Garner Special Attention In 2009

Cardiovascular diseases, Orthopedics, Diabetes care and Women’s health related products will be keenly watched out for in 2009 as these issues account for the majority of people’s health concerns. Existing products that might have been slow to take off might find their way to the top of the market segments due to factors like better post launch numbers, lack of better alternatives, cost effectiveness and efficacy. Products like Breast Tomosynthesis should have a high impact once launched because of the product’s contrast-enhanced 3-D imaging and reduction or elimination of overlapping tissue. Although some of the products are extensions of existing products they nonetheless improve efficiency and overcome some of the disadvantages and limitations of existing products.   High Volume And Low Value Of Deals Will Be A Norm In The Medical Equipment Mergers And Acquisitions Landscape In 2009

Medical Equipment Deals in 2009 are likely to continue to be high in volume but relatively low in value, a trend set in 2008. Average deal values have come down in 2008 when compared with the same time period for 2007, while on the other side the deal volumes went up.

From January 1st to November 5th, deal values in the medical equipment industry stood at $77,000 million with a deal volume of 556. For the same time period in 2007, the value of deals stood at more than $90,000 million and the number of deals at 428. This clearly shows that the companies are avoiding big one off investments due to lack of cash flow in the markets and tighter lending policies. Instead of investing in one big company or a product, companies are looking for investment across the market to leverage their positions. Markets that have been gaining a lot of attention are Healthcare IT, Interventional Cardiology and In-Vitro Diagnostics. These markets along with hospital supplies and home healthcare equipment represent high growth markets both in the developed and emerging economies.

For vast range of market reports you can visit: [] Or Contact us at:

Bharat Book Bureau Phone : +91 22 2757 8668 Fax : +91 22 2757 9131 E-mail : Website :

About Bharat Book Bureau

Bharat Book Bureau facilitates companies to take the lead of their industry with best practice business strategies and intelligence, through a unique combination of published reports, databases, country reports, company profiles and customized research services. Bharat Book Bureau provides strategic information tools to the executives, business analysts, and knowledge managers that will help them to probe into and support critical, timely business decisions and strategies.

Press Release Source:

Press Release Submitted On: March 16, 2009 at 3:39 am
This article has been viewed 92473 time(s).